Andrew P. Brogan

1.3k total citations
18 papers, 863 citations indexed

About

Andrew P. Brogan is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Andrew P. Brogan has authored 18 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Organic Chemistry. Recurrent topics in Andrew P. Brogan's work include Asymmetric Synthesis and Catalysis (3 papers), HIV/AIDS Research and Interventions (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Andrew P. Brogan is often cited by papers focused on Asymmetric Synthesis and Catalysis (3 papers), HIV/AIDS Research and Interventions (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Andrew P. Brogan collaborates with scholars based in United States, United Kingdom and Switzerland. Andrew P. Brogan's co-authors include Tobin J. Dickerson, Kim D. Janda, Claude J. Rogers, Gunnar F. Kaufmann, Michaël M. Meijler, Bruce Clapham, Jason A. Moss, Sang‐Hyeup Lee, Peter E. Wright and H. Jane Dyson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Andrew P. Brogan

17 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew P. Brogan United States 12 527 200 194 95 83 18 863
Mekhala Pati United States 7 352 0.7× 146 0.7× 124 0.6× 65 0.7× 243 2.9× 10 874
Sheryl A. Hyland United States 12 374 0.7× 179 0.9× 211 1.1× 60 0.6× 151 1.8× 12 709
Jared B. J. Milbank United States 11 895 1.7× 329 1.6× 203 1.0× 169 1.8× 283 3.4× 17 1.2k
Laure Maigre France 16 191 0.4× 108 0.5× 160 0.8× 42 0.4× 248 3.0× 22 656
M Takano Japan 15 351 0.7× 81 0.4× 276 1.4× 62 0.7× 32 0.4× 27 1.0k
Takeshi Murata Japan 16 327 0.6× 117 0.6× 167 0.9× 131 1.4× 281 3.4× 56 854
Hartmut Drechsel Germany 17 480 0.9× 254 1.3× 76 0.4× 57 0.6× 56 0.7× 22 1.0k
Vanessa V. Phelan United States 18 812 1.5× 85 0.4× 112 0.6× 31 0.3× 75 0.9× 27 1.2k
Holger Paulsen Germany 13 610 1.2× 159 0.8× 262 1.4× 20 0.2× 107 1.3× 23 1.1k
Beth A. Rasmussen United States 17 512 1.0× 152 0.8× 234 1.2× 105 1.1× 511 6.2× 22 1.1k

Countries citing papers authored by Andrew P. Brogan

Since Specialization
Citations

This map shows the geographic impact of Andrew P. Brogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Brogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Brogan more than expected).

Fields of papers citing papers by Andrew P. Brogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Brogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Brogan. The network helps show where Andrew P. Brogan may publish in the future.

Co-authorship network of co-authors of Andrew P. Brogan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Brogan. A scholar is included among the top collaborators of Andrew P. Brogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Brogan. Andrew P. Brogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Schneider, Stefan, Gary Blick, Douglas G. Ward, et al.. (2024). Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study. Infectious Diseases and Therapy. 13(4). 891–906. 3 indexed citations
4.
Brogan, Andrew P., et al.. (2019). Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States. Journal of Managed Care & Specialty Pharmacy. 25(12). 1319–1327. 7 indexed citations
5.
Brogan, Andrew P., et al.. (2017). Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples. Journal of Managed Care & Specialty Pharmacy. 23(2). 125–134. 35 indexed citations
6.
Earnshaw, Stephanie, Andrew P. Brogan, & Cheryl McDade. (2013). Model-Based Cost-Effectiveness Analyses for Prostate Cancer Chemoprevention. PharmacoEconomics. 31(4). 289–304. 5 indexed citations
7.
Brogan, Andrew P., Tobin J. Dickerson, & Kim D. Janda. (2007). Nornicotine-organocatalyzed aqueous reduction of α,β-unsaturated aldehydes. Chemical Communications. 4952–4952. 15 indexed citations
8.
Brogan, Andrew P., Lisa M. Eubanks, George F. Koob, Tobin J. Dickerson, & Kim D. Janda. (2007). Antibody-Catalyzed Oxidation of Δ9-Tetrahydrocannabinol. Journal of the American Chemical Society. 129(12). 3698–3702. 7 indexed citations
9.
Kravchenko, Vladimir V., Gunnar F. Kaufmann, John C. Mathison, et al.. (2006). N-(3-Oxo-acyl)homoserine Lactones Signal Cell Activation through a Mechanism distinct from the Canonical Pathogen-associated Molecular Pattern Recognition Receptor Pathways. Journal of Biological Chemistry. 281(39). 28822–28830. 103 indexed citations
10.
Brogan, Andrew P., Tobin J. Dickerson, & Kim D. Janda. (2006). Enamine‐Based Aldol Organocatalysis in Water: Are They Really “All Wet”?. Angewandte Chemie. 118(48). 8278–8280. 84 indexed citations
11.
Brogan, Andrew P., Jacob Verghese, William R. Widger, & Harold Kohn. (2005). Bismuth–dithiol inhibition of the Escherichia coli rho transcription termination factor. Journal of Inorganic Biochemistry. 99(3). 841–851. 12 indexed citations
12.
Skordalakes, Emmanuel, et al.. (2005). Structural Mechanism of Inhibition of the Rho Transcription Termination Factor by the Antibiotic Bicyclomycin. Structure. 13(1). 99–109. 51 indexed citations
13.
Yao, Yuanyuan, Maria A. Martinez‐Yamout, Tobin J. Dickerson, et al.. (2005). Structure of the Escherichia coli Quorum Sensing Protein SdiA: Activation of the Folding Switch by Acyl Homoserine Lactones. Journal of Molecular Biology. 355(2). 262–273. 144 indexed citations
14.
Rogers, Claude J., Tobin J. Dickerson, Andrew P. Brogan, & Kim D. Janda. (2005). Hammett Correlation of Nornicotine Analogues in the Aqueous Aldol Reaction:  Implications for Green Organocatalysis. The Journal of Organic Chemistry. 70(9). 3705–3708. 52 indexed citations
15.
Brogan, Andrew P., Tobin J. Dickerson, Grant E. Boldt, & Kim D. Janda. (2005). Altered retinoid homeostasis catalyzed by a nicotine metabolite: Implications in macular degeneration and normal development. Proceedings of the National Academy of Sciences. 102(30). 10433–10438. 26 indexed citations
16.
Brogan, Andrew P., et al.. (2005). Development of a Technique to Determine Bicyclomycin-Rho Binding and Stoichiometry by Isothermal Titration Calorimetry and Mass Spectrometry. Journal of the American Chemical Society. 127(8). 2741–2751. 19 indexed citations
17.
Kaufmann, Gunnar F., Sang‐Hyeup Lee, Claude J. Rogers, et al.. (2004). Revisiting quorum sensing: Discovery of additional chemical and biological functions for 3-oxo- N -acylhomoserine lactones. Proceedings of the National Academy of Sciences. 102(2). 309–314. 279 indexed citations
18.
Brogan, Andrew P., William R. Widger, & Harold Kohn. (2003). Bicyclomycin Fluorescent Probes:  Synthesis and Biochemical, Biophysical, and Biological Properties. The Journal of Organic Chemistry. 68(14). 5575–5587. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mekhala Pati Breakdown of academic impact, for papers by Sheryl A. Hyland Breakdown of academic impact, for papers by Jared B. J. Milbank Breakdown of academic impact, for papers by Laure Maigre Breakdown of academic impact, for papers by M Takano Breakdown of academic impact, for papers by Takeshi Murata Breakdown of academic impact, for papers by Hartmut Drechsel Breakdown of academic impact, for papers by Vanessa V. Phelan Breakdown of academic impact, for papers by Holger Paulsen Breakdown of academic impact, for papers by Beth A. Rasmussen
Rankless by CCL
2026